21 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
in place to safeguard personal data and requires us to adopt appropriate privacy governance including policies, procedures, training and data audit. We
ARS
kcfebhn2bw4kivhz30np
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
kfhr 2hiq6lrq6lpk7
18 Apr 23
Preliminary proxy
7:59am
DEF 14A
zkszbvc hln4ou
26 Apr 21
Definitive proxy
4:22pm
424B4
waniqqfag m0
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
ddrlc
28 Sep 20
IPO registration (amended)
6:07am
S-1
EX-10.11
lvw56nm
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.13
h54v2w5l35q9 5j2a6s
10 Sep 20
IPO registration
5:26pm
S-1
EX-10.9
jhcjqb
10 Sep 20
IPO registration
5:26pm
S-1
2ii h77hu
10 Sep 20
IPO registration
5:26pm
DRS
y1b611 3qg9deqm5u45
6 Aug 20
Draft registration statement
12:00am
DRS
EX-10.8
e4dnr8 za
6 Aug 20
Draft registration statement
12:00am